David Fajgenbaum, MD, MBA, MSc, is a physician-scientist at the University of Pennsylvania, co-Founder & President of the Castleman Disease Collaborative Network, and national bestselling author of ‘Chasing My Cure: A Doctor’s Race to Turn Hope Into Action‘. He is also a patient battling a deadly disease called idiopathic multicentric Castleman disease (iMCD), which he discovered a treatment for that is saving his life and others. Through his work at the University of Pennsylvania’s Center for Cytokine Storm Treatment & Laboratory, he has also identified and advanced 16 other treatment approaches for iMCD and cancer. Fajgenbaum currently leads over 20 translational research studies including the CORONA Project, which is the world’s largest effort to identify, track, and advance COVID-19 treatments. He also co-leads Every Cure, a non-profit drug development organization focused on advancing repurposed treatments, and serves on the Board of Directors for the Reagan-Udall Foundation for the FDA. Fajgenbaum has published scientific papers in high-impact journals such as the New England Journal of Medicine, Journal of Clinical Investigation, and The Lancet, been recognized with awards such as the 2016 Atlas Award which he received along with then Vice President Joe Biden, and been profiled in a New York Times cover story as well as by Good Morning America, CNN, Forbes 30 Under 30, and the Today Show. Dr. Fajgenbaum earned a BS from Georgetown University, MSc from the University of Oxford, MD from the University of Pennsylvania, and MBA from The Wharton School.